Bicycle Therapeutics plc Interest and Other Income
Bicycle Therapeutics plc (BCYC) reported Interest and Other Income of $4.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-07-30
- Bicycle Therapeutics plc interest and other income for the quarter ending 2026-06-30 was $4.36M, a 41.66% decline year-over-year.
- Bicycle Therapeutics plc interest and other income for the quarter ending 2026-03-31 was $4.88M, a 42.04% decline year-over-year.
- Bicycle Therapeutics plc interest and other income for the quarter ending 2025-12-31 was $5.88M, a 42.97% decline year-over-year.
- Bicycle Therapeutics plc interest and other income for the quarter ending 2025-09-30 was $6.70M, a 36.69% decline year-over-year.
- Bicycle Therapeutics plc interest and other income for fiscal 2025 was $28.46M, a 16.98% decline from fiscal 2024.
- Bicycle Therapeutics plc interest and other income for fiscal 2024 was $34.28M, a 144.85% increase from fiscal 2023.
- Bicycle Therapeutics plc interest and other income for fiscal 2023 was $14.00M, a 143.26% increase from fiscal 2022.
- Bicycle Therapeutics plc interest and other income for fiscal 2022 was $5.76M, a 4696.67% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.36M 10-Q · filed 2026-07-30 | $9.24M 10-Q · filed 2026-07-30 | $15.11M derived: sum of 3 quarters · filed 2026-07-30 | $21.81M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $4.88M 10-Q · filed 2026-04-30 | $10.75M derived: sum of 2 quarters · filed 2026-04-30 | $17.45M derived: sum of 3 quarters · filed 2026-04-30 | $24.93M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $12.58M derived: sum of 2 quarters · filed 2026-03-17 | $20.05M derived: sum of 3 quarters · filed 2026-07-30 | $28.46M 10-K · filed 2026-03-17 |
| 2025-09-30 | $6.70M 10-Q · filed 2025-10-30 | $14.17M derived: sum of 2 quarters · filed 2026-07-30 | $22.59M 10-Q · filed 2025-10-30 | $32.89M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $7.47M 10-Q · filed 2026-07-30 | $15.89M 10-Q · filed 2026-07-30 | $26.19M derived: sum of 3 quarters · filed 2026-07-30 | $36.77M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $8.41M 10-Q · filed 2026-04-30 | $18.72M derived: sum of 2 quarters · filed 2026-04-30 | $29.30M derived: sum of 3 quarters · filed 2026-04-30 | $37.07M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $20.89M derived: sum of 2 quarters · filed 2026-03-17 | $28.66M derived: sum of 3 quarters · filed 2026-03-17 | $34.28M 10-K · filed 2026-03-17 |
| 2024-09-30 | $10.58M 10-Q · filed 2025-10-30 | $18.36M derived: sum of 2 quarters · filed 2025-10-30 | $23.98M 10-Q · filed 2025-10-30 | $30.26M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | $7.77M 10-Q · filed 2025-08-08 | $13.40M 10-Q · filed 2025-08-08 | $19.67M derived: sum of 3 quarters · filed 2026-03-17 | $23.66M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | $5.62M 10-Q · filed 2025-05-01 | $11.90M derived: sum of 2 quarters · filed 2026-03-17 | $15.88M derived: sum of 3 quarters · filed 2026-03-17 | $16.70M derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | $6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $10.26M derived: sum of 2 quarters · filed 2026-03-17 | $11.07M derived: sum of 3 quarters · filed 2026-03-17 | $14.00M 10-K · filed 2026-03-17 |
| 2023-09-30 | $3.98M 10-Q · filed 2024-10-31 | $4.80M derived: sum of 2 quarters · filed 2024-10-31 | $7.73M 10-Q · filed 2024-10-31 | $10.37M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $812.00K 10-Q · filed 2024-08-06 | $3.74M 10-Q · filed 2024-08-06 | $6.38M derived: sum of 3 quarters · filed 2025-02-25 | $8.37M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $2.93M 10-Q · filed 2024-05-02 | $5.57M derived: sum of 2 quarters · filed 2025-02-25 | $7.56M derived: sum of 3 quarters · filed 2025-02-25 | $8.47M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $4.63M derived: sum of 2 quarters · filed 2025-02-25 | $5.54M derived: sum of 3 quarters · filed 2025-02-25 | $5.76M 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.99M 10-Q · filed 2023-11-02 | $2.90M derived: sum of 2 quarters · filed 2023-11-02 | $3.12M 10-Q · filed 2023-11-02 | $3.18M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $908.00K 10-Q · filed 2023-08-03 | $1.13M 10-Q · filed 2023-08-03 | $1.19M derived: sum of 3 quarters · filed 2024-02-20 | $1.21M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $218.00K 10-Q · filed 2023-05-04 | $277.00K derived: sum of 2 quarters · filed 2024-02-20 | $301.00K derived: sum of 3 quarters · filed 2024-02-20 | $324.00K derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $83.00K derived: sum of 2 quarters · filed 2024-02-20 | $106.00K derived: sum of 3 quarters · filed 2024-02-20 | $120.00K 10-K · filed 2024-02-20 |
| 2021-09-30 | $24.00K 10-Q · filed 2022-11-03 | $47.00K derived: sum of 2 quarters · filed 2022-11-03 | $61.00K 10-Q · filed 2022-11-03 | $90.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $23.00K 10-Q · filed 2022-08-04 | $38.00K 10-Q · filed 2022-08-04 | $66.00K derived: sum of 3 quarters · filed 2023-02-28 | $138.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $15.00K 10-Q · filed 2022-05-05 | $43.00K derived: sum of 2 quarters · filed 2023-02-28 | $115.00K derived: sum of 3 quarters · filed 2023-02-28 | $486.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $100.00K derived: sum of 2 quarters · filed 2023-02-28 | $471.00K derived: sum of 3 quarters · filed 2023-02-28 | $683.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $72.00K 10-Q · filed 2021-11-04 | $443.00K derived: sum of 2 quarters · filed 2021-11-04 | $655.00K 10-Q · filed 2021-11-04 | $875.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $371.00K 10-Q · filed 2021-08-05 | $583.00K 10-Q · filed 2021-08-05 | $803.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.24M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $212.00K 10-Q · filed 2021-05-06 | $432.00K derived: sum of 2 quarters · filed 2022-03-01 | $872.00K derived: sum of 3 quarters · filed 2022-03-01 | $962.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $660.00K derived: sum of 2 quarters · filed 2022-03-01 | $750.00K derived: sum of 3 quarters · filed 2022-03-01 | $814.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $440.00K 10-Q · filed 2020-11-05 | $530.00K derived: sum of 2 quarters · filed 2020-11-05 | $594.00K 10-Q · filed 2020-11-05 | $688.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $90.00K 10-Q · filed 2020-08-05 | $154.00K 10-Q · filed 2020-08-05 | $248.00K derived: sum of 3 quarters · filed 2021-03-11 | $274.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $64.00K 10-Q · filed 2020-05-07 | $158.00K derived: sum of 2 quarters · filed 2021-03-11 | $184.00K derived: sum of 3 quarters · filed 2021-03-11 | $236.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $120.00K derived: sum of 2 quarters · filed 2021-03-11 | $172.00K derived: sum of 3 quarters · filed 2021-03-11 | $169.00K 10-K · filed 2021-03-11 |
| 2018-09-30 | $26.00K 10-Q · filed 2019-11-07 | $78.00K derived: sum of 2 quarters · filed 2019-11-07 | $75.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $52.00K 10-Q · filed 2019-08-08 | $49.00K 10-Q · filed 2019-08-08 | ||
| 2017-12-31 | $50.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |